Kaiser Permanente Chemical Dependency Recovery Program

Kaiser Permanente Chemical Dependency Recovery Program

Services:
Facility Operation (e.g., Private, Public)
• Private for-profit organization

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Family counseling
• Smoking/vaping/tobacco cessation counseling
• Individual counseling
• Substance use disorder education
• Group counseling
• Marital/couples counseling

Other Services

• Treatment for gambling disorder

Facility Smoking Policy

• Smoking not permitted

Transitional Services

• Outcome follow-up after discharge
• Naloxone and overdose education
• Discharge Planning
• Aftercare/continuing care

External Opioid Medications Source

• Other contracted prescribing entity

Treatment Approaches

• Motivational interviewing
• Telemedicine/telehealth therapy
• 12-step facilitation
• Substance use disorder counseling
• Trauma-related counseling
• Cognitive behavioral therapy
• Brief intervention
• Relapse prevention

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Type of Opioid Treatment

• Prescribes naltrexone
• Buprenorphine maintenance
• Relapse prevention with naltrexone
• Prescribes buprenorphine
• Accepts clients using MAT but prescribed elsewhere

Gender Accepted

• Female
• Male

Ancillary Services

• Suicide prevention services
• Case management service
• Mental health services
• Acupuncture
• Social skills development

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Recovery Support Services

• Mentoring/peer support
• Self-help groups
• Assistance with obtaining social services

Age Groups Accepted

• Adults
• Seniors

Detoxification (medical withdrawal) Services

• Opioids detoxification
• Alcohol Detoxification
• Benzodiazepines Detoxification
• Cocaine Detoxification
• Medication routinely used during detoxification
• Methamphetamines detoxification

Payment/Insurance/Funding Accepted

• Medicaid
• Medicare
• Private health insurance

Hospitals

• General Hospital (including VA hospital)

License/Certification/Accreditation

• State Substance use treatment agency
• State department of health
• State mental health department
• Hospital licensing authority

Special Programs/Groups Offered

• Adult women
• Adolescents
• Young adults
• Clients who have experienced trauma
• Adult men
• Clients with co-occurring mental and substance use disorders

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Facility Vaping Policy

• Vaping not permitted

Language Services

• Sign language services for the deaf and hard of hearing

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient day treatment or partial hospitalization
• Outpatient
• Regular outpatient treatment
• Outpatient detoxification
• Intensive outpatient treatment

Pharmacotherapies

• Medication for mental disorders
• Buprenorphine with naloxone
• Clonidine
• Acamprosate (Campral®)
• Buprenorphine without naloxone
• Naltrexone (oral)
• Nicotine replacement
• Non-nicotine smoking/tobacco cessation
• Disulfiram
• Naltrexone (extended-release, injectable)
• Buprenorphine (extended-release, injectable)

Testing

• TB screening
• HIV testing
• Testing for Hepatitis C (HCV)
• Testing for Hepatitis B (HBV)
• Breathalyzer or blood alcohol testing
• Drug or alcohol urine screening
• STD testing
• Metabolic syndrome monitoring

Type of Care

• Detoxification
• Substance use treatment

Assessment/Pre-treatment

• Outreach to persons in the community
• Comprehensive mental health assessment
• Professional interventionist/educational consultant
• Comprehensive substance use assessment
• Screening for substance use
• Complete medical history/physical exam
• Screening for mental disorders
• Interim services for clients
• Screening for tobacco use